Hormonal contraceptive use after a first venous thrombotic event and the risk of recurrence in premenopausal women-Reference-Cited by-同舟云学术

Hormonal contraceptive use after a first venous thrombotic event and the risk of recurrence in premenopausal women

Published:2024-08 Issue:8 Volume:22 Page:2195-2202
ISSN:1538-7836
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:Journal of Thrombosis and Haemostasis

Author:

Verlaan Judith P.L.,Stegeman Bernadine H.,Timp Jasmijn F.,Scheres Luuk J.J.,Flinterman Linda E.,Helmerhorst Frans M.,Rosendaal Frits R.,Cannegieter Suzanne C.,van Hylckama Vlieg Astrid

Funder

Nederlandse Hartstichting

Trombosestichting Nederland

Publisher

Elsevier BV

Reference26 articles.

1. Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization collaborative study of cardiovascular disease and steroid hormone contraception;Lancet,1995

2. American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism;Ortel;Blood Adv,2020

3. Antithrombotic therapy for VTE disease: second update of the CHEST Guideline and Expert Panel Report;Stevens;Chest,2021

4. Thrombophilia, clinical factors, and recurrent venous thrombotic events;Christiansen;JAMA,2005

5. Hormonal contraceptive use after venous thrombosis: practice from 1999 to 2004;Stegeman;J Endocrinol Metab,2014

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Venous thromboembolism and estrogen—dance with the devil in thrombosis medicine;Journal of Thrombosis and Haemostasis;2024-08